← Back to Search

Healthy Adult Speakers for Speech

N/A

Waitlist Available

Led By Carrie Niziolek, PhD

Research Sponsored by University of Wisconsin, Madison

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

English-speaking adults

No history of stroke or neurological conditions

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 hour

Awards & highlights

Study Summary

This trial aims to study how the brain processes and controls speech in healthy individuals. By understanding this, researchers hope to identify how people perceive their own speech errors and learn new speech sounds. This information may

Who is the study for?

This trial is for healthy individuals interested in how the brain controls speech. Participants should be available for 4 visits, each lasting 2-4 hours. The eligibility criteria are not fully listed here, so potential participants would need to contact the researchers for more details.Check my eligibility

What is being tested?

The study is testing the effects of Transcranial Magnetic Stimulation (TMS) on speech processing and control during speaking tasks. It aims to understand how people perceive their own speech errors and learn new sounds.See study design

What are the potential side effects?

While specific side effects are not detailed here, TMS can sometimes cause discomfort at the stimulation site, headache, lightheadedness or seizures in rare cases.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am an adult who speaks English.

Select...

I have never had a stroke or neurological conditions.

Select...

I can hear and speak normally.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 hour

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 hour

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acoustic vowel space measures: AVS (acoustic vowel spacing)/VSA (vowel space area)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Healthy Adult SpeakersExperimental Treatment2 Interventions

healthy adult participants across the lifespan in three groups:18-35, 36-55, and 56+

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Speaking Tasks

2021

N/A

~20

TMS

2021

Completed Phase 2

~2170

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor

1,191 Previous Clinical Trials

3,169,681 Total Patients Enrolled

3 Trials studying Speech

149 Patients Enrolled for Speech

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH

330 Previous Clinical Trials

178,456 Total Patients Enrolled

11 Trials studying Speech

1,376 Patients Enrolled for Speech

Carrie Niziolek, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison

3 Previous Clinical Trials

149 Total Patients Enrolled

3 Trials studying Speech

149 Patients Enrolled for Speech

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals are eligible to participate in this clinical trial?

"To be eligible for participation in this clinical trial, individuals must possess the ability to communicate verbally and fall within the age range of 18 to 70 years. A total of 15 participants will be enrolled in this study."

Answered by AI

Is this particular research study enrolling individuals who are above the age of 55?

"To be eligible for this trial, applicants must fall within the age range of 18 to 70. It's worth noting that there are separate trials available specifically designed for individuals under 18 years old (2 trials) and those over 65 (8 trials)."

Answered by AI

Are researchers currently accepting participants for this study?

"According to the details provided on clinicaltrials.gov, this particular trial is not currently seeking participants. The study was initially posted on August 1st, 2024 and last updated on January 22nd, 2024. It's important to note that while this specific study is not actively enrolling candidates at present, there are indeed twelve other ongoing studies currently recruiting eligible patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)

2024. "Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06234059.

All > Transcranial Magnetic Stimulation